Risk factors for brain metastases in patients with non–small‐cell lung cancer

Ning An, Jing Wang, Haoyi Wang, Ji Li, Yang Liu, Jinming Yu, Hui ZhuCancer 2018 · DOI

TL;DR

This review synthesizes current knowledge on risk factors for brain metastases (BM) in non-small-cell lung cancer (NSCLC) patients. Identifying these factors is crucial for optimizing prophylactic cranial irradiation (PCI) and improving patient outcomes, as PCI's benefit is controversial and not universally applicable.

What Problem Does This Paper Address?

Brain metastases (BM) are a significant and severe complication for patients with non-small-cell lung cancer (NSCLC), leading to poor quality of life and reduced survival. While prophylactic cranial irradiation (PCI) has been used to prevent BM, its effectiveness in improving overall survival is debated, and it carries potential risks and side effects. This creates a critical need to identify specific patient subgroups who are at higher risk for developing BM and would therefore benefit most from PCI, while avoiding unnecessary treatment for those who would not. This paper addresses this by reviewing and consolidating existing research on the various factors that contribute to the development of BM in NSCLC patients.

Methods

This paper is a comprehensive review article. The authors systematically searched and analyzed existing literature on risk factors for brain metastases in NSCLC. They synthesized findings from numerous studies, categorizing risk factors into several key areas: pathology, gender, T and N statuses, tumor stages, age, performance status, tumor markers, and oncogene mutations. The review focuses on identifying consistent trends and conflicting findings across studies to provide a consolidated understanding of the current state of knowledge.

Datasets

Not discussed in the paper. The paper is a review of existing literature and does not present new experimental data or datasets.

Key Insights and Ideas

  • Pathology Matters, But With Nuance: Adenocarcinoma and non-squamous cell carcinoma subtypes appear to be associated with a higher risk of BM, though some studies show no significant correlation, possibly due to variations in BM assessment methods.
  • Age as a Predictor: Younger age (generally <60-70 years) is consistently identified as a risk factor for BM, with potential explanations involving differences in the angiogenic microenvironment.
  • The Role of Lymph Node Status: More advanced lymph node involvement, particularly multiple metastases in mediastinal lymph nodes, is a strong predictor of BM.
  • Tumor Markers as Indicators: Elevated serum levels of neuron-specific enolase (NSE) and carcinoembryonic antigen (CEA) are emerging as significant independent risk factors for BM.
  • Oncogenes as Emerging Factors: EGFR mutations are increasingly recognized as an independent risk factor for BM, especially in East Asian populations. ALK mutations and high tumor mutational burden (TMB) are also suggested to be associated with increased BM incidence, though more research is needed.
  • The Need for Stratification: The ultimate goal is to develop robust models for predicting BM risk, enabling personalized treatment decisions, particularly regarding the use of PCI.

Key Results

The review consolidates findings from numerous studies, highlighting several key risk factors:

  • Pathology: Adenocarcinoma and non-squamous cell carcinoma types are associated with increased BM risk (e.g., RR of 2.86 for adenocarcinoma in operable NSCLC).
  • Age: Patients younger than 60-70 years are at higher risk (e.g., HR of 2.03 for age <60).
  • Lymph Node Status: Advanced lymph node involvement (e.g., N2-3, hilar, or homolateral mediastinal nodes) significantly increases BM risk.
  • Tumor Markers: Elevated serum NSE and CEA levels are linked to higher BM incidence. For instance, CEA concentrations ≥40 ng/mL were an independent risk factor (RR 11.4).
  • Oncogenes: EGFR mutations are associated with a nearly twofold higher risk of BM.

Limitations and Future Work

The authors acknowledge several limitations and suggest future directions:

  • Variability in Studies: Differences in study methodologies, patient populations (e.g., locally advanced vs. resectable NSCLC), and BM assessment techniques contribute to conflicting findings for some risk factors.
  • Need for Further Validation: While some oncogene mutations (like EGFR) show promise as risk factors, more extensive research is needed to confirm their predictive value and understand the underlying mechanisms.
  • Developing Predictive Models: The paper emphasizes the need for more robust nomograms and models that integrate these identified risk factors, including oncogene status, to accurately predict BM occurrence and guide therapeutic decisions, particularly for PCI.
  • Understanding Mechanisms: Further investigation into the biological mechanisms underlying BM development, such as the role of the tumor microenvironment and specific molecular pathways, is crucial.

Summary updated

Abstract

Brain metastases (BM) are severe incidents in patients with non-small-cell lung cancer (NSCLC). The controversial value of prophylactic cranial irradiation (PCI) in NSCLC in terms of survival benefit prompted us to explore the possible risk factors for BM in NSCLC and identify the potential population most likely to benefit from PCI. Risk factors for brain metastases in NSCLC are reviewed in this article. Identifying patients with a higher risk of BM could possibly increase the benefit of PCI while reducing the discomfort and risks caused by unnecessary invasive procedures in the NSCLC patient population. Future studies might focus on finding a solid basis for the prediction of the occurrence of brain metastases and for the therapeutic decision on the use of PCI.
BibTeX
@inproceedings{an2018risk,
  author = {Ning An and Jing Wang and Haoyi Wang and Ji Li and Yang Liu and Jinming Yu and Hui Zhu},
  title = {{Risk factors for brain metastases in patients with non–small‐cell lung cancer}},
  booktitle = {Cancer},
  year = {2018},
  doi = {10.1002/cam4.1865},
}
Figure